Brian Tanquilut Analyst PerformanceSr. Equity Research Analyst - Healthcare Services and Healthcare Information Technology/Digital Heal at Jefferies Financial GroupBrian Tanquilut is a stock analyst at Jefferies Financial Group focused in the healthcare sector, covering 29 publicly traded companies. Over the past year, Brian Tanquilut has issued 32 stock ratings, including buy and hold recommendations. While full access to Brian Tanquilut's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brian Tanquilut's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings127 Last 11 YearsBuy Recommendations54.84% 68 Buy RatingsCompanies Covered29 Unique Companies Ratings Distribution124RatingsDistribution of strong buy, buy, hold, and sell ratings by Brian Tanquilut.RatingPercentageCount Strong Buy0.0%0 ratings Buy54.8%68 ratings Hold45.2%56 ratings Sell0.0%0 ratingsOut of 124 total stock ratings issued by Brian Tanquilut at Jefferies Financial Group, the majority (54.8%) have been Buy recommendations, followed by 45.2% Hold.Best & Worst CallsBest Call0000.0%AVAHJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CYHJun 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE55.2% of companies on NYSE16 companiesNASDAQ44.8% of companies on NASDAQ13 companiesBrian Tanquilut, an analyst at Jefferies Financial Group, currently covers 29 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageHealthcare26 companies89.7%Consumer Discretionary2 companies6.9%Consumer Staples1 company3.4%Brian Tanquilut of Jefferies Financial Group specializes in stock coverage within the Healthcare sector, with additional focus on Consumer Discretionary and Consumer Staples companies.Coverage IndustriesIndustryPercentageHEALTHCARE PROVIDERS & SERVICES24 companies82.8%HEALTHCARE TECHNOLOGY2 companies6.9%SPECIALTY RETAIL2 companies6.9%PERSONAL CARE PRODUCTS1 company3.4% Brian Tanquilut's Ratings History at Jefferies Financial Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsODDODDITY Tech9/9/2026Boost Price Target$16.48$18.00Hold$0.0000.00% ROIPGNYProgyny9/8/2026Set Price Target$25.94$33.00$0.0000.00% ROIAHCOAdaptHealth7/21/2026Upgrade$10.98$13.00Buy$0.0000.00% ROIACHCAcadia Healthcare6/3/2026Upgrade$24.42$30.00Buy$0.0000.00% ROIDOCSDoximity5/14/2026Downgrade$23.52$19.00Hold$0.0000.00% ROIAHCOAdaptHealth4/20/2026Reiterated Rating$12.72$11.00Hold$0.0000.00% ROIGRDNGuardian Pharmacy Services3/30/2026Initiated Coverage$34.19$44.00Buy$0.0000.00% ROIPGNYProgyny3/6/2026Reiterated Rating$17.51$30.00Buy$0.0000.00% ROIEYENational Vision3/5/2026Reiterated Rating$27.70$40.00Buy$0.0000.00% ROIRDNTRadNet3/3/2026Reiterated Rating$71.83$91.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. SGRYSurgery Partners3/3/2026Set Price Target$13.66$30.00$0.0000.00% ROIODDODDITY Tech2/25/2026Downgrade$13.65$18.00Hold$0.0000.00% ROIEHABEnhabit2/23/2026Downgrade$13.59$13.80Hold$0.0000.00% ROIWAYWaystar2/18/2026Reiterated Rating$25.41$41.00Buy$0.0000.00% ROITHCTenet Healthcare2/12/2026Boost Price Target$229.56$265.00Buy$0.0000.00% ROIHCAHCA Healthcare1/28/2026Boost Price Target$489.02$590.00Buy$0.0000.00% ROICORCencora1/22/2026Upgrade$351.72Buy$0.0000.00% ROICHEChemed1/22/2026Downgrade$453.27Hold$0.0000.00% ROIACHCAcadia Healthcare1/22/2026Downgrade$14.33Hold$0.0000.00% ROIACHCAcadia Healthcare1/22/2026Reiterated Rating$14.33$15.00Hold$0.0000.00% ROICHEChemed1/22/2026Reiterated Rating$453.27$475.00Hold$0.0000.00% ROICORCencora1/22/2026Upgrade$351.72$440.00Buy$0.0000.00% ROICAHCardinal Health1/22/2026Boost Price Target$208.75$270.00Buy$0.0000.00% ROIHCAHCA Healthcare1/22/2026Boost Price Target$467.95$535.00Buy$0.0000.00% ROIOPCHOption Care Health1/13/2026Reiterated Rating$34.85$37.00Buy$0.0000.00% ROICAHCardinal Health11/3/2025Set Price Target$190.22$220.00Buy$0.0000.00% ROIHCAHCA Healthcare10/28/2025Boost Price Target$465.50$525.00Buy$0.0000.00% ROIAVAHAveanna Healthcare10/28/2025Boost Price Target$9.72$12.50Buy$0.0000.00% ROIPNTGThe Pennant Group10/24/2025Initiated Coverage$24.48$30.00Buy$0.0000.00% ROIBTSGBrightSpring Health Services10/21/2025Set Price Target$32.32$36.00Buy$0.0000.00% ROIMCKMcKesson10/13/2025Boost Price Target$768.79$900.00Buy$0.0000.00% ROIODDODDITY Tech9/24/2025Initiated Coverage$61.06$78.00Buy$0.0000.00% ROICHEChemed9/2/2025Upgrade$458.62$550.00Buy$000.0000.00% ROICAHCardinal Health8/12/2025Set Price Target$158.07$150.00$000.0000.00% ROICHEChemed7/25/2025Initiated Coverage$463.64$500.00Hold$000.0000.00% ROICYHCommunity Health Systems7/24/2025Reiterated Rating$3.88$3.00Hold$0.0000.00% ROIAVAHAveanna Healthcare7/21/2025Upgrade$3.96$6.00Buy$0.0000.00% ROICVSCVS Health6/30/2025Boost Price Target$68.71$80.00Buy$000.0000.00% ROICAHCardinal Health2/5/2025Upgrade$125.29$150.00Buy$000.0000.00% ROIOPCHOption Care Health1/23/2025Upgrade$29.31$35.00Buy$00.0000.00% ROIThe cat is out the bag (Ad)Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.Watch Porter Stansberry's full investigation into the Final Displacement nowRDNTRadNet1/15/2025Lower Price Target$61.19$80.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageJefferies Financial GroupBMO Capital MarketsWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
